
Keywords: فاس لیگاند; AT; adipose tissue; BM; bone marrow; CsA; cyclosporine A; COX-2; cyclooxygenase-2; DEX; dexamethasone; DMEM; Dulbeccós modified Eaglés medium; DMSO; dimethyl sulfoxide; ELISA; enzyme-linked immunosorbent assay; FasL; Fas ligand; HGF; hepatocyte growth f